Chris Gemmiti
Directeur des opérations chez Sentien Biotechnologies, Inc.
Postes actifs de Chris Gemmiti
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Sentien Biotechnologies, Inc.
 Sentien Biotechnologies, Inc. BiotechnologyHealth Technology Sentien Biotechnologies, Inc. develops cell-based therapy for critical care. It provides the Sentinel, a device that actively treats patients during a dialysis dose by supplementing patient blood with MSC-derived secretions. The company was founded by Brian Miller and Biju Parekkadan and is headquartered in Lexington, MA. | Directeur des opérations | - | - |
Historique de carrière de Chris Gemmiti
Statistiques
Internationale
| Etats-Unis | 2 |
Opérationnelle
| Chief Operating Officer | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Sentien Biotechnologies, Inc.
Sentien Biotechnologies, Inc. BiotechnologyHealth Technology Sentien Biotechnologies, Inc. develops cell-based therapy for critical care. It provides the Sentinel, a device that actively treats patients during a dialysis dose by supplementing patient blood with MSC-derived secretions. The company was founded by Brian Miller and Biju Parekkadan and is headquartered in Lexington, MA. | Health Technology |
- Bourse
- Insiders
- Chris Gemmiti
- Expérience
